Home/Filings/4/0001104659-19-039324
4//SEC Filing

Furey John 4

Accession 0001104659-19-039324

CIK 0001621227other

Filed

Jul 2, 8:00 PM ET

Accepted

Jul 3, 5:00 PM ET

Size

5.4 KB

Accession

0001104659-19-039324

Insider Transaction Report

Form 4
Period: 2019-07-02
Furey John
Director
Transactions
  • Award

    Option to purchase Ordinary Shares

    2019-07-02+240,541240,541 total
    Exercise: $0.61From: 2020-07-02Exp: 2029-07-02Ordinary Shares (240,541 underlying)
Footnotes (1)
  • [F1]The exercise price was converted from GBP0.48 based on an exchange rate of $U.S. 1.2638 to GBP1.00. The actual exercise price will be the pounds sterling amount.

Documents

1 file

Issuer

Adaptimmune Therapeutics PLC

CIK 0001621227

Entity typeother

Related Parties

1
  • filerCIK 0001691218

Filing Metadata

Form type
4
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 5:00 PM ET
Size
5.4 KB